Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma (RAD001)

This study has been terminated.
(delayed recruitment)
Sponsor:
Information provided by (Responsible Party):
Heinrich-Heine University, Duesseldorf
ClinicalTrials.gov Identifier:
NCT00933374
First received: July 3, 2009
Last updated: March 17, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)